Nindanib 150 Soft Gelatin Capsule
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Nintedanib (150mg)
Overview Nindanib 150 Soft Gelatin Capsule
Nindanib 150 mg soft gelatin capsules treat idiopathic pulmonary fibrosis and non-small cell lung carcinoma by inhibiting specific molecular pathways crucial to disease progression, thus hindering cancer cell proliferation. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, potentially requiring several weeks or months; discontinue only under medical guidance. Diarrhea is a frequent side effect; maintain adequate hydration and report persistent symptoms. Other common side effects include nausea, abdominal discomfort, emesis, elevated liver enzymes, anorexia, cephalalgia, weight reduction, and hypertension. Liver function monitoring via blood tests may be required. Prior to initiating treatment, disclose any bleeding disorders, hepatic or renal impairment, or concurrent use of anti-infectives. Significant drug interactions are possible; inform your healthcare provider of all medications. This medication is contraindicated during gestation and lactation; reliable contraception is essential for both partners throughout treatment.
Uses of Nindanib 150 Soft Gelatin Capsule
Managing idiopathic pulmonary fibrosis and non-small cell lung cancer.
Major Benefits of Nindanib 150 Soft Gelatin Capsule:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. The Nindanib 150 mg softgel should be administered with a meal.
Common Side effects of Nindanib 150 Soft Gelatin Capsule:
- Diarrhea
- Nausea
- Abdominal pain
- Vomiting
- Abnormal liver function tests
- Loss of appetite
- Headache
- Weight loss
- High blood pressure
How to use Nindanib 150 Soft Gelatin Capsule:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. The Nindanib 150 mg softgel should be administered with a meal.
How Nindanib 150 Soft Gelatin Capsule works:
Nindanib 150 mg soft gelatin capsules are an anti-cancer drug that inhibits the activity of aberrant proteins responsible for stimulating cancer cell proliferation. The medication also interferes with biological pathways leading to fibrosis – the excessive build-up of scar tissue – thereby hindering or retarding cancer metastasis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while taking Nindanib 150 Soft Gelatin Capsules is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Nindanib 150 mg soft gelatin capsules during pregnancy poses a confirmed risk to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where potential benefits outweigh the dangers. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of 150 mg Nindanib soft gelatin capsules while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 150mg nindanib soft gelatin capsule may induce adverse reactions that impair driving ability. Nausea is a possible side effect, potentially affecting safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using nindanib 150 mg soft gelatin capsules. Dosage modification may be necessary; physician consultation is recommended. Data regarding the use of nindanib 150 mg soft gelatin capsules in such patients is scarce.
LiverCAUTION
Patients with liver impairment should use Nindanib 150 mg soft gelatin capsules cautiously, potentially requiring dosage modification. Consult a physician before use. Nindanib 150 mg soft gelatin capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Nindanib 150 Soft Gelatin Capsule :
Omit any missed Nindanib 150 mg softgel dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Nindanib 150 Soft Gelatin Capsule
| Label | Value |
|---|---|
| Chemical Classification | Indole-2-carboxylic acids |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently